CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Mason KA, Neal R, Hunter N, Ariga H, Ang K, Milas L.
Mason KA, et al. Among authors: neal r.
Radiother Oncol. 2006 Aug;80(2):192-8. doi: 10.1016/j.radonc.2006.07.024. Epub 2006 Aug 14.
Radiother Oncol. 2006.
PMID: 16905212
Cancer Res 2004;64:5074-7] and non-immunogenic [Mason KA, Ariga H, Neal R, et al. Targeting toll-like receptor-9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. ...
Cancer Res 2004;64:5074-7] and non-immunogenic [Mason KA, Ariga H, Neal R, et al. Targeting toll-like receptor-9 with CpG olig …